Lin Elizabeth Yeu
SEC insider (Form 3/4/5 filer). CIK 0001842190. Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS) and 1 other issuer. 23 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in IRVINE, CA.
Companies Lin Elizabeth Yeu has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Officer, Chief Medical Officer
- STAAR SURGICAL CO (STAA): Director
Lin Elizabeth Yeu
CIK: 0001842190
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect5.4K shares at avg. $85.00$458K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect5.4K shares at avg. $90.00$485K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect1.6K shares at avg. $85.00$135K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect1.6K shares at avg. $90.00$143K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect5.4K shares at avg. $80.00$431K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleIndirect1.6K shares at avg. $80.00$127K - Sep 1, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.6K shares at avg. $73.86$340K - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect390 shares at avg. $67.00$26K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect379 shares at avg. $68.71$26K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect375 shares at avg. $69.42$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,387 | $85.00 | $457,895 | Direct |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,386 | $90.00 | $484,740 | Direct |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $85.00 | $135,150 | Indirect |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $90.00 | $143,100 | Indirect |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,387 | $80.00 | $430,960 | Direct |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $80.00 | $127,200 | Indirect |
| Sep 1, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,601 | $73.86 | $339,830 | Direct |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 390 | $67.00 | $26,130 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 379 | $68.71 | $26,041 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 375 | $69.42 | $26,033 | Direct |
1-10 of 23 transactions